In TP53-mutated myeloid malignancies, recurrent copy number loss, structural variants, and chromothripsis often involve large regions on chr5 and chr7 that are well established through conventional cytogenetics and other studies[4]. This evidence concerns the gene TP53 and myeloid neoplasm.